Lifetime Duration of Depressive Disorders in Patients With Type 2 Diabetes

Mary de Groot, Kent A Crick, Molly Long, Chandan Saha, Jay H Shubrook, Mary de Groot, Kent A Crick, Molly Long, Chandan Saha, Jay H Shubrook

Abstract

Objective: Depression in patients with type 2 diabetes (T2D) is associated with long-term complications, disability, and early mortality. No studies have systematically examined the length of episodes and remission in adults with major depressive disorder (MDD) and T2D. This study examined the course of depressive disorders in patients with T2D and MDD.

Research design and methods: Participants (N = 50) enrolled in a behavioral intervention for adults with T2D and MDD were interviewed using the Structured Clinical Interview for DSM-IV-TR to assess history of depressive disorders at baseline (lifetime history), postintervention, and 3-month follow-up. Onset and remission dates were recorded for all Axis I depressive disorders from birth to final interview.

Results: Average number of MDD episodes was 1.8 with a mean duration of 23.4 months (SD 31.9; range 0.5-231.3). Over the life course, mean exposure to MDD was 43.1 months (SD 46.5; range 0.5-231.3). Kaplan-Meier survival curve analysis indicated median episode duration decreased with subsequent episodes (14 months, first episode; 9 months, second episode; P < 0.002). In patients with multiple depressive episodes, recovery time was shorter with each subsequent episode (P = 0.002). No differences in length of episode or remission were observed based on chronology of T2D diagnosis.

Conclusions: The overall exposure to depression in this sample of adults with T2D represents a substantial period of time that can contribute to negative medical and psychiatric outcomes. Recurrent episodes decrease in duration as do recovery periods, resulting in a waxing and waning pattern. Findings from this study underscore the need to effectively diagnose and treat depression in patients with T2D to minimize risk of future depressive episodes.

© 2016 by the American Diabetes Association.

Figures

Figure 1
Figure 1
Kaplan-Meier survival curves. A: Time to first and second recurrences. B: Time to second and third recurrences. C: Time to first and second remissions. D: Time to first and third remissions.

References

    1. Centers for Disease Control and Prevention National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, U.S. Department of Health and Human Services, 2014
    1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069–1078
    1. Holt RI, de Groot M, Lucki I, Hunter CM, Sartorius N, Golden SH. NIDDK international conference report on diabetes and depression: current understanding and future directions. Diabetes Care 2014;37:2067–2077
    1. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000;23:934–942
    1. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001;63:619–630
    1. Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM. Depression and coronary heart disease in women with diabetes. Psychosom Med 2003;65:376–383
    1. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278–3285
    1. Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 2003;25:246–252
    1. Wagner JA, Tennen H, Osborn CY. Lifetime depression and diabetes self-management in women with type 2 diabetes: a case-control study. Diabet Med 2010;27:713–717
    1. Jacobson AM, de Groot M, Samson JA. The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus. Qual Life Res 1997;6:11–20
    1. Von Korff M, Katon W, Lin EH, et al. . Potentially modifiable factors associated with disability among people with diabetes. Psychosom Med 2005;67:233–240
    1. Katon WJ, Rutter C, Simon G, et al. . The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005;28:2668–2672
    1. Lin EH, Heckbert SR, Rutter CM, et al. . Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med 2009;7:414–421
    1. Lustman PJ, Griffith LS, Clouse RE, Cryer PE. Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control. J Nerv Ment Dis 1986;174:736–742
    1. Lustman PJ, Griffith LS, Clouse RE. Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care 1988;11:605–612
    1. Lustman PJ, Griffith LS, Freedland KE, Clouse RE. The course of major depression in diabetes. Gen Hosp Psychiatry 1997;19:138–143
    1. Fisher L, Skaff MM, Mullan JT, Arean P, Glasgow R, Masharani U. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med 2008;25:1096–1101
    1. Psychiatric Disorders in America: the Epidemiologic Catchment Area Study. Robins L, Regier D, Eds. New York, The Free Press, 1991
    1. Unützer J, Katon W, Callahan CM, et al. .; IMPACT Investigators. Improving Mood-Promoting Access to Collaborative Treatment . Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 2002;288:2836–2845
    1. Shapiro RW, Keller MB. Initial 6-month follow-up of patients with major depressive disorder. A preliminary report from the NIMH collaborative study of the psychobiology of depression. J Affect Disord 1981;3:205–220
    1. Kessler RC, Berglund P, Demler O, et al. .; National Comorbidity Survey Replication . The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095–3105
    1. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008;31:2383–2390
    1. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996;19:1097–1102
    1. Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999;22:1071–1076
    1. Golden SH, Lazo M, Carnethon M, et al. . Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008;299:2751–2759
    1. Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetic adults. Diabetes Care 1999;22:448–452
    1. de Groot M, Doyle T, Averyt J, Risaliti C, Shubroo J. Depressive symptoms and type 2 diabetes mellitus in rural appalachia: an 18-month follow-up study. Int J Psychiatry Med 2015;48:263–277
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition- Text Revision. Washington, DC, American Psychological Association 2000.
    1. Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 2012;21:169–184
    1. Mueller TI, Leon AC, Keller MB, et al. . Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999;156:1000–1006
    1. de Groot M, Kushnick M, Doyle T, et al. . A model of community-based behavioral intervention for depression in diabetes: Program ACTIVE. Diabetes Spectr 2010;23:18–25
    1. de Groot M, Doyle T, Kushnick M, et al. . Can lifestyle interventions do more than reduce diabetes risk? Treating depression in adults with type 2 diabetes with exercise and cognitive behavioral therapy. Curr Diab Rep 2012;12:157–166
    1. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 1992;49:624–629
    1. Solomon DA, Keller MB, Leon AC, et al. . Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry 1997;54:1001–1006
    1. Eaton WW, Anthony JC, Gallo J, et al. . Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry 1997;54:993–999
    1. Spijker J, de Graaf R, Bijl RV, Beekman AT, Ormel J, Nolen WA. Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry 2002;181:208–213
    1. Solomon DA, Keller MB, Leon AC, et al. . Multiple recurrences of major depressive disorder. Am J Psychiatry 2000;157:229–233
    1. Pintor L, Gastó C, Navarro V, Torres X, Fañanas L. Relapse of major depression after complete and partial remission during a 2-year follow-up. J Affect Disord 2003;73:237–244
    1. Judd LL, Akiskal HS, Maser JD, et al. . Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 1998;50:97–108
    1. Judd LL, Paulus MJ, Schettler PJ, et al. . Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000;157:1501–1504
    1. Post RM. Heading off depressive illness evolution and progression to treatment resistance. Dialogues Clin Neurosci 2015;17:105–109

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe